Incannex Healthcare (IXHL) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $2.88, +0.70% vs the prior close of $2.86.
- Volume 86.70K shares, 1.0x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
IXHL rises 0.7% to $2.88. Closed at $2.88, +0.70% vs the prior close of $2.86. Day range $2.75–$2.90, opened at $2.84.
IXHL daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — IXHL rises 0.7% to $2.88
- Closed at $2.88, +0.70% vs the prior close of $2.86. Day range $2.75–$2.90, opened at $2.84.
- Volume was 86.70K shares, 1.0x its 50-day average of 85.19K.
- Price is -13.2% vs its 50-day average ($3.32) and -38.6% vs its 200-day average ($4.69).
- 52-week range $2.49–$14.91; today's close sits at 3% of that range, 80.7% below the 52-week high.
Oct 14, 2026 — IXHL dips 1.7% to $2.86, a 6-month low
- Closed at $2.86, -1.72% vs the prior close of $2.91. Day range $2.84–$2.93, opened at $2.91.
- Volume was 79.50K shares, 0.9x its 50-day average of 85.87K.
- Price is -13.9% vs its 50-day average ($3.32) and -39.6% vs its 200-day average ($4.73).
- 52-week range $2.49–$14.91; today's close sits at 3% of that range, 80.8% below the 52-week high.
Oct 13, 2026 — IXHL rises 0.3% to $2.91
- Closed at $2.91, +0.34% vs the prior close of $2.90. Day range $2.88–$2.99, opened at $2.95.
- Volume was 57.30K shares, 0.7x its 50-day average of 87.87K.
- Price is -12.4% vs its 50-day average ($3.32) and -39.1% vs its 200-day average ($4.78).
- 52-week range $2.49–$14.91; today's close sits at 3% of that range, 80.5% below the 52-week high.
Oct 12, 2026 — IXHL slides 6.5% to $2.90, a 6-month low
- Closed at $2.90, -6.45% vs the prior close of $3.10. Day range $2.85–$3.10, opened at $3.04.
- Volume was 148.60K shares, 1.7x its 50-day average of 86.33K.
- Price is -12.7% vs its 50-day average ($3.32) and -39.9% vs its 200-day average ($4.83).
- 52-week range $2.49–$14.91; today's close sits at 3% of that range, 80.5% below the 52-week high.
Oct 9, 2026 — IXHL slides 3.1% to $3.10, a 1-month low
- Closed at $3.10, -3.13% vs the prior close of $3.20. Day range $3.09–$3.24, opened at $3.17.
- Volume was 43.40K shares, 0.5x its 50-day average of 86.94K — lighter than usual.
- Price is -6.7% vs its 50-day average ($3.32) and -36.4% vs its 200-day average ($4.87).
- 52-week range $2.49–$14.91; today's close sits at 5% of that range, 79.2% below the 52-week high.
Oct 8, 2026 — IXHL rises 0.6% to $3.20
- Closed at $3.20, +0.63% vs the prior close of $3.18. Day range $3.13–$3.25, opened at $3.17.
- Volume was 47.60K shares, 0.5x its 50-day average of 87.87K — lighter than usual.
- Price is -3.6% vs its 50-day average ($3.32) and -35.0% vs its 200-day average ($4.92).
- 52-week range $2.49–$14.91; today's close sits at 6% of that range, 78.5% below the 52-week high.
Oct 7, 2026 — IXHL rises 0.3% to $3.18
- Closed at $3.18, +0.32% vs the prior close of $3.17. Day range $3.13–$3.20, opened at $3.13.
- Volume was 26.40K shares, 0.3x its 50-day average of 88.65K — lighter than usual.
- Price is -4.1% vs its 50-day average ($3.31) and -36.0% vs its 200-day average ($4.97).
- 52-week range $2.49–$14.91; today's close sits at 6% of that range, 78.7% below the 52-week high.
Oct 6, 2026 — IXHL dips 1.2% to $3.17, 3 down days in a row
- Closed at $3.17, -1.25% vs the prior close of $3.21. Day range $3.13–$3.30, opened at $3.20.
- Volume was 62.20K shares, 0.7x its 50-day average of 89.19K.
- Price is -4.2% vs its 50-day average ($3.31) and -36.8% vs its 200-day average ($5.02).
- 52-week range $2.49–$14.94; today's close sits at 5% of that range, 78.8% below the 52-week high.
- That makes 3 straight losses.
Oct 5, 2026 — IXHL ends flat (+0.0%) to $3.21
- Closed at $3.21, +0.00% vs the prior close of $3.21. Day range $3.15–$3.23, opened at $3.18.
- Volume was 27.90K shares, 0.3x its 50-day average of 90.65K — lighter than usual.
- Price is -2.9% vs its 50-day average ($3.31) and -36.6% vs its 200-day average ($5.06).
- 52-week range $2.49–$15.00; today's close sits at 6% of that range, 78.6% below the 52-week high.
Oct 2, 2026 — IXHL dips 1.2% to $3.21
- Closed at $3.21, -1.23% vs the prior close of $3.25. Day range $3.20–$3.33, opened at $3.32.
- Volume was 52.10K shares, 0.6x its 50-day average of 91.29K — lighter than usual.
- Price is -2.8% vs its 50-day average ($3.30) and -37.2% vs its 200-day average ($5.11).
- 52-week range $2.49–$15.00; today's close sits at 6% of that range, 78.6% below the 52-week high.
IXHL latest news & SEC filings
Every SEC filing by or about IXHL in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 25, 2026 · Form 10-K — Annual report
Annual report (audited full-year financial statements and business review)
Fiscal year ended Jun 30, 2026:
- Net income: -$19.30M (prior year -$46.88M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$1.66 (prior year -$40.82) (loss narrowed vs Jun 30, 2025)
Sep 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 25, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jun 25, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade IXHL
- How much it moves: over the last 20 sessions the average daily move was 2.09% (largest 6.5%).
- Liquidity: about 70.33K shares (≈$202.55K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.88 vs a range of $2.49–$14.91 (3% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:30 on Feb 27, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 10-K Sep 25, 2026; 8-K Sep 9, 2026; 8-K Aug 25, 2026.
- Share count: 12.54M shares outstanding (Sep 24, 2026), -96.4% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
IXHL market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 2.84 | 2.90 | 2.75 | 2.88 | 86.70K |
| Oct 14, 2026 | 2.91 | 2.93 | 2.84 | 2.86 | 79.50K |
| Oct 13, 2026 | 2.95 | 2.99 | 2.88 | 2.91 | 57.30K |
| Oct 12, 2026 | 3.04 | 3.10 | 2.85 | 2.90 | 148.60K |
| Oct 9, 2026 | 3.17 | 3.24 | 3.09 | 3.10 | 43.40K |
| Oct 8, 2026 | 3.17 | 3.25 | 3.13 | 3.20 | 47.60K |
| Oct 7, 2026 | 3.13 | 3.20 | 3.13 | 3.18 | 26.40K |
| Oct 6, 2026 | 3.20 | 3.30 | 3.13 | 3.17 | 62.20K |
| Oct 5, 2026 | 3.18 | 3.23 | 3.15 | 3.21 | 27.90K |
| Oct 2, 2026 | 3.32 | 3.33 | 3.20 | 3.21 | 52.10K |
| Oct 1, 2026 | 3.23 | 3.33 | 3.20 | 3.25 | 41.00K |
| Sep 30, 2026 | 3.35 | 3.35 | 3.20 | 3.24 | 35.90K |
| Sep 29, 2026 | 3.18 | 3.35 | 3.16 | 3.31 | 43.70K |
| Sep 28, 2026 | 3.26 | 3.27 | 3.13 | 3.15 | 130.20K |
| Sep 25, 2026 | 3.38 | 3.38 | 3.26 | 3.32 | 145.20K |
| Sep 24, 2026 | 3.47 | 3.47 | 3.37 | 3.40 | 60.00K |
| Sep 23, 2026 | 3.38 | 3.54 | 3.37 | 3.44 | 73.60K |
| Sep 22, 2026 | 3.48 | 3.60 | 3.38 | 3.39 | 63.00K |
| Sep 21, 2026 | 3.64 | 3.72 | 3.48 | 3.49 | 90.10K |
| Sep 18, 2026 | 3.58 | 3.72 | 3.42 | 3.64 | 92.20K |
About Incannex Healthcare
Incannex Healthcare (IXHL) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in NORWEST NSW. State of incorporation: DE. Fiscal year ends June 30. SEC CIK 1873875.
IXHL board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| George Anastassov | Director | Nov 14, 2025 |
| Robert Clark | Director | Nov 14, 2025 |
| Joel Latham | CEO and President | Nov 14, 2025 |
| Troy Valentine | Director | Nov 14, 2025 |
| Peter Widdows | Director | Nov 14, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Joel Latham | CEO and President | Nov 14, 2025 |
| Joseph Swan | CFO, Treasurer and Secretary | Nov 14, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
IXHL financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Jun 30, 2026 | — | $-19.30M | -1.66 | $-12.87M |
| Jun 30, 2025 | — | $-46.88M | -40.82 | $-12.51M |
| Jun 30, 2024 | $12.00K | $-18.46M | -1.15 | $-15.85M |
| Jun 30, 2023 | — | $-48.81M | -3.32 | $-10.75M |
Latest balance sheet: total assets $72.98M, total liabilities $5.61M, cash $67.71M (as of Jun 30, 2026).
IXHL earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on IXHL
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.